XWELL (XWEL) Cash And Cash Equivalents

: $8.44 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

XWELL's quarterly cash and cash equivalents declined from Jun. 2023 ($6.38 Mil) to Sep. 2023 ($4.83 Mil) but then increased from Sep. 2023 ($4.83 Mil) to Dec. 2023 ($8.44 Mil).

XWELL's annual cash and cash equivalents declined from Dec. 2021 ($105.51 Mil) to Dec. 2022 ($19.04 Mil) and declined from Dec. 2022 ($19.04 Mil) to Dec. 2023 ($8.44 Mil).

XWELL Cash And Cash Equivalents Historical Data

The historical data trend for XWELL's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XWELL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

2.18

89.80

105.51

19.04

8.44

XWELL Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															19.04	9.87	6.38	4.83	8.44

XWELL Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

XWELL (NAS:XWEL) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

XWELL Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of XWELL's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

XWELL (XWEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (NAS:XWEL) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

254 West 31st Street, 11th Floor, New York, NY, USA, 10001

Website

https://www.xwell.com

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

Executives

Suzanne A. Scrabis	officer: Chief Financial Officer	C/O XWELL, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Robert Weinstein	director	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Scott R Milford	officer: Chief Executive Officer	C/O TOWN SPORTS INTERNATIONAL, LLC, 5 PENN PLAZA, NEW YORK NY 10001
Bruce Bernstein	director	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
Ezra Ernst	officer: See Remarks	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Omar Haynes	officer: VP Treas & Fi & Interim CFO	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Doug Satzman	director, officer: Chief Executive Officer	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
James A. Berry	officer: Chief Financial Officer	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Michael Lebowitz	director	780 THIRD AVENUE, 12TH FLOOR, C/O XPRESSPA GROUP, INC., NEW YORK NY 10017
Donald E. Stout	director	780 THIRD AVENUE, 15TH FLOOR, NEW YORK NY 10017
Mistral Spa Holdings, Llc	10 percent owner	C/O MISTRAL CAPITAL MANAGEMENT, LLC, 650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Mistral Capital Management, Llc	10 percent owner	650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Andrew R Heyer	other: Former director and 10% owner	501 MADISON AVENUE, FLOOR 5, NEW YORK NY 10019
Calm.com, Inc.	10 percent owner	140 2ND STREET, THIRD FLOOR, SAN FRANCISCO CA 94105
Edward Jankowski	officer: SVP; CEO of XpresSpa	C/O FORM HOLDINGS CORP., 780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017